- Product Details
Keywords
- Dronedarone
- Dronedarone powder
- Dronedarone price
Quick Details
- ProName: Supply high quality Dronedarone powder
- CasNo: 141626-36-0
- Molecular Formula: C31H44N2O5S
- Appearance: Yellow to off-yellow powder
- Application: treatment of atrial fibrillation
- DeliveryTime: Within 3 days after receving the payme...
- PackAge: 1kg/tin
- Port: Guangzhou
- ProductionCapacity: 1000 Kilogram/Month
- Purity: 99%min
- Storage: Melting point 140℃~145℃
- Transportation: EMS or Sea transportation
- LimitNum: 1 Gram
- Moisture Content: 0.1%
- Impurity: 0.1%
Superiority
Competive advantages
1.Rich experience
We specialize in this filed for many years,our steriods and hormones exported to all over the world and established long friendly relations of coroperation with them.
2.Great quality,purity and favorable
Good quality is one of our biggest secert to success;u can get the best quality and service from us.
3.Safest and fastest delivery
We have adequate stock so that we can deliver the products with 24 hours as soon as receiving the payment.Fast and discreet shipment will be arranged to pass customs.
4.Good package
Unique ways to ship 10g to 100kg powders to your destination.We offer melting powder into liquid service and ship the liquid in special bottles.
5.Great after-sales service
Any questions or problems after receiving the product,pls feel free to contact us.Problems would be solved immediately.
Details
Dronedarone is a mainly for the indication of cardiac arrhythmias. It was approved by the FDA on July 2, 2009. It was recommended as an alternative to amiodarone for the treatment of atrial fibrillation and atrial flutter in people whose hearts have either returned to normal rhythm or who undergo drug therapy or electric shock treatment i.e. direct current cardioversion (DCCV) to maintain normal rhythm. In the United States, the FDA approved label includes a claim for reducing hospitalization, but not for reducing mortality, as a reduction in mortality was not demonstrated in the clinical development program. A trial of the drug in heart failure was stopped as an interim analysis showed a possible increase in heart failure deaths, in patients with moderate to severe CHF.
COA of our Dronedarone Hydrochloride
Items |
Specifications |
Result |
Description |
Yellow to off-yellow powder |
Complies |
Identification |
HPLC:Sample peak retention time peak retention time should be consistent with the reference substance |
complies |
UV :The UV spectrum is consistent with the reference substance |
||
IR |
Complies |
|
PH |
4.0-6.0 |
4.50 |
Related substance |
Total impurity:≤1.0% |
0.30% |
Single impurity:≤0.1% |
0.08% |
|
Chloride:≤0.02% |
Complies |
|
Sulfide:≤0.02% |
Complies |
|
Assay |
≥99% |
100.30% |
Melting point |
140℃~145℃ |
141.2℃~142.8℃ |
Residue on ignition |
≤0.1% |
0.07% |
Loss on dry |
≤0.5% |
0.38% |
Heavy metals |
≤20ppm |
Complies |
Conclusion |
Complies |